Osteosarcoma: Clinical Trials

25 trials for Osteosarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed, 4 terminated, 3 recruiting, 3 unknown. 25 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 325Completed 11, Terminated 4, Recruiting 3, Unknown 3, Active not recruiting 2, Suspended 1, Withdrawn 1
Phase 26Unknown 3, Completed 1, Suspended 1, Terminated 1

Follow Osteosarcoma: new trials by email Literature Review of Osteosarcoma trials Research Report on Osteosarcoma

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (ie. 1 cycle) during 12 cycles - Osteosarcoma, Pediatric Osteosarcoma
Phase 3RecruitingGustave Roussy, Cancer Campus, Grand Paris5302026-10-072026-10-26
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - CIC-Rearranged Sarcoma, Metastatic Ewing Sarcoma
Phase 2 / Phase 3TerminatedChildren's Oncology Group22025-11-102026-10-05
Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure
HS-20093, Gemcitabine combined with docetaxel - Osteosarcoma
Phase 3CompletedHansoh BioMedical R&D Company1222025-04-252026-10-19
Use of GnRHa During Chemotherapy for Fertility Protection
Triptorelin Embonate, Sodium Chloride solution 0.9% - Breast Cancer Female, Acute Leukemia
Phase 3RecruitingKenny Rodriguez-Wallberg5002023-03-312023-10-27
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Bone Scan, Cabozantinib S-malate, Cisplatin - High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2 / Phase 3SuspendedNational Cancer Institute (NCI)11222023-03-032026-10-27
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Biospecimen Collection, Computed Tomography, Questionnaire Administration - Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3RecruitingChildren's Oncology Group622022-04-012026-08-25
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Doxorubicin, Cisplatin, Methotrexate, Doxorubicin, Cisplatin - Osteosarcoma, Neoplasms, Connective Tissue
Phase 2 / Phase 3UnknownBlokhin's Russian Cancer Research Center502022-01-102024-04-01
Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.
Tranexamic acid injection, Saline - Ewing Sarcoma of Bone, Osteosarcoma
Phase 3CompletedChildren's Cancer Hospital Egypt 57357482021-08-022024-02-07
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
Vigil, Irinotecan, Temozolomide - Ewing Sarcoma, Ewing Family of Tumors
Phase 3TerminatedGradalis, Inc.322018-08-212023-04-26
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer
Triptorelin (GnRHa) + Chemotherapy - Cancer, Toxicity Due to Chemotherapy
Phase 2 / Phase 3UnknownAssistance Publique - Hôpitaux de Paris112016-11-232019-12-17
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
apatinib - Osteosarcoma, Metastasis
Phase 2 / Phase 3CompletedGUO WEI372016-03-012018-04-23
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Cyclophosphamide, Doxorubicin, Doxorubicin Hydrochloride - Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone
Phase 3Active not recruitingNational Cancer Institute (NCI)3122014-12-122026-11-13
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
filgrastim - Childhood Choroid Plexus Tumor, Childhood Medulloblastoma
Phase 3TerminatedBarbara Ann Karmanos Cancer Institute232013-08-012020-10-29
Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients
External Beam Radiotherapy - Ewing's Sarcoma
Phase 3WithdrawnChildren's Cancer Hospital Egypt 573572012-09-012016-01-12
Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
High Dose Methotrexate - Osteosarcoma
Phase 3CompletedThe Hospital for Sick Children62010-10-012021-10-28
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
cyproheptadine hydrochloride, placebo - Cancer
Phase 3TerminatedUniversity of South Florida222010-06-012015-07-02
Study in Localized and Disseminated Ewing Sarcoma
Zoledronic acid, Busulfan, Treosulfan - Ewing's Sarcoma
Phase 3CompletedUniversity Hospital Muenster9072009-10-012019-10-22
Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma
Standard treatment (as per protocol ISG SSG III), Intensified chemotherapy - Ewing's Sarcoma
Phase 3CompletedItalian Sarcoma Group2782009-01-222022-09-19
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
sodium thiosulfate, examination - Brain Tumor, Central Nervous System Tumor
Phase 3CompletedChildren's Oncology Group1312008-06-232023-11-09
Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
Zoledronic acid, Standard chemotherapy - Osteosarcoma
Phase 2 / Phase 3UnknownTata Memorial Hospital602008-05-012011-06-23

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Sarcoma, Ewing (9)  ·  Sarcoma (8)  ·  Medulloblastoma (4)  ·  Neoplasms (4)  ·  Choroid Plexus Neoplasms (3)  ·  Neuroblastoma (3)  ·  Neuroectodermal Tumors, Primitive, Peripheral (3)  ·  Testicular Neoplasms (3)  ·  Astrocytoma (2)  ·  Bone Neoplasms (2)  ·  Brain Neoplasms (2)  ·  Chondrosarcoma (2)  ·  Glioblastoma (2)  ·  Hepatoblastoma (2)

Broader conditions

Neoplasms by Histologic Type (24)  ·  Neoplasms, Bone Tissue (24)  ·  Neoplasms, Connective Tissue (23)  ·  Neoplasms, Connective and Soft Tissue (23)  ·  Neoplasms (21)  ·  Sarcoma (17)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (6)  ·  Neoplasms by Site (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Neoplasms, Nerve Tissue (5)  ·  Neuroectodermal Tumors (5)  ·  Brain Diseases (4)

Interventions

Doxorubicin (9)  ·  Ifosfamide (6)  ·  Methotrexate (6)  ·  Etoposide (5)  ·  Cisplatin (4)  ·  Cyclophosphamide (3)  ·  Vincristine (3)  ·  Zoledronic Acid (3)  ·  1,2-diaminocyclohexaneplatinum II citrate (2)  ·  Busulfan (2)  ·  Irinotecan (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Platinum (2)  ·  Radiation (2)  ·  Specimen Handling (2)

Sponsors

Children's Oncology Group (4)  ·  National Cancer Institute (NCI) (3)  ·  Children's Cancer Hospital Egypt 57357 (2)  ·  Gustave Roussy, Cancer Campus, Grand Paris (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Barbara Ann Karmanos Cancer Institute (1)  ·  Blokhin's Russian Cancer Research Center (1)  ·  GUO WEI (1)  ·  Gradalis, Inc. (1)  ·  Hansoh BioMedical R&D Company (1)  ·  INSYS Therapeutics Inc (1)  ·  Italian Sarcoma Group (1)  ·  Kenny Rodriguez-Wallberg (1)  ·  Tata Memorial Hospital (1)  ·  The Hospital for Sick Children (1)

Countries

United States (11)  ·  Canada (6)  ·  Australia (4)  ·  France (4)  ·  New Zealand (3)  ·  Puerto Rico (3)  ·  China (2)  ·  Egypt (2)  ·  Italy (2)  ·  Sweden (2)  ·  Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  India (1)  ·  Netherlands (1)

Top investigators

Abha Gupta, MD (1)  ·  Alan W Craft, Prof Sir MD (1)  ·  Beniamin Bokhyan, PhD (1)  ·  Bhuvana A Setty (1)  ·  Chantal Kalifa, MD (1)  ·  David R. Freyer, DO, MS (1)  ·  Jeffrey P. Krischer, PhD (1)  ·  John J Doski (1)  ·  John Nemunaitis, MD (1)  ·  Larry Dillaha, MD (1)  ·  Laurence Brugieres, MD (1)  ·  Manish Agarwal, M.S(Orth) (1)

Results publications

PMID 31401903, PMID 17267204, PMID 22480131, PMID 25421877, PMID 26271204, PMID 27020837, PMID 27324280, PMID 27569442, PMID 27914822, PMID 28619014, PMID 29791011, PMID 31553693, PMID 35246418, PMID 35427190, PMID 36669140, PMID 38070906, PMID 38524902, PMID 39796745, PMID 39833645, PMID 42208702

NIH funding

U10CA180886 (5), U10CA098543 (2), 2004 (1), 2008 (1), 2015 (1), 2023 (1), P30CA022453 (1), U10CA081920 (1)